Dominik Kölmel

Dominik Kölmel has extensive work experience in the field of chemistry and research. Dominik is currently the Director of Chemistry at Odyssey Therapeutics since October 2021. Prior to that, they worked at Pfizer as a Principal Scientist from May 2020 to September 2021 and as a Senior Scientist from November 2017 to May 2020. Dominik also gained research experience at Princeton University as a Postdoctoral Research Fellow from June 2016 to September 2017, at Stanford University as a Postdoctoral Research Fellow from March 2014 to May 2016, and at Karlsruhe Institute of Technology / University of Karlsruhe as a Postdoc from September 2013 to February 2014.

Dominik Kölmel received a Diploma in Chemistry from the Karlsruhe Institute of Technology (KIT) in 2010. Dominik further pursued their education at KIT and obtained a Dr. rer. nat. in Organic Chemistry in 2013.